Project cooperationUpdated on 10 January 2026
ForecomAI: Enhanced Image Analysis for Next-Generation NAM Platforms
CEO at ForecomAI
London, United Kingdom
About
We offer AI and multimodal computational capabilities suited to the development, optimisation, and validation of NAM platforms under HORIZON-HLTH-2026-01-TOOL-03. Our expertise includes: (i) quantitative cell morphology modelling from fluorescence and brightfield imaging; (ii) protein subcellular localisation; and (iii) multimodal architectures integrating imaging with gene, protein, and compound information to support mechanism-of-action inference, quality control, and predictive performance. We are seeking partners forming consortia to build scalable, human-relevant NAMs using iPSC-derived systems, organoids, or organ-on-chip models, particularly where high-content imaging and rigorous image analysis are necessary to improve disease-modelling precision, support regulatory-aligned validation strategies, and enhance confidence in AI-enabled predictions.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Translational NAMs in pharmacology & toxicology for drug profiling
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Nikolas Dietis
Assistant Professor of Pharmacology at University of Cyprus
Nicosia, Cyprus
Project cooperation
Collaborate or Co-ordinate in HORIZON-HLTH-2026-01-TOOL-03
Kathy Gately
Clinical Senior Lecturer at Trinity College Dublin & Trinity St James's Cancer Institute (TSJCI)
Dublin, Ireland
Project cooperation
Advancing Single-Molecule De-Novo Protein Sequencing
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Til Schlotter
ETH Researcher, Co-founder & CEO at UNOMR AG
Zurich, Switzerland